Profound Treg perturbations correlate with COVID-19 severity
Silvia Galván-Peña(Harvard University), Molly Thomas(Oregon Health & Science University), Nihaarika Sharma(Massachusetts General Hospital), Daniel A. Michelson(Harvard University), Zachary Manickas-Hill(Ragon Institute of MGH, MIT and Harvard), Bruce D. Walker(Howard Hughes Medical Institute), Irena Gushterova(Broad Institute), Kendall M. Lavin-Parsons(Massachusetts General Hospital), Blair A. Parry(Massachusetts General Hospital), Juliette Léon(Hôpital Necker-Enfants Malades), Brendan M. Lilley(Massachusetts General Hospital), Kathryn Hall(Harvard University), Jonathan Z. Li(Brigham and Women's Hospital), Hargun K. Khanna(Massachusetts General Hospital), Christophe Benoıst(Harvard University), Felicia Chen(Boston University), Musie Ghebremichael(Ragon Institute of MGH, MIT and Harvard), Brinda Vijaykumar(Harvard University), Brian C. Russo(Harvard University), Anna Gonye(Broad Institute), Jessica Tantivit(Broad Institute), Moshe Sade-Feldman(Harvard University), Angela M. Magnuson(Harvard University), Alicja Piechocka‐Trocha(Harvard University), Kasidet Manakongtreecheep(Broad Institute), Maricarmen Rojas-López(Harvard University), Nicole C. Charland(Massachusetts General Hospital), Xu G. Yu(Massachusetts General Hospital), Diane Mathis(Harvard University), Justin Margolin(Massachusetts General Hospital), Daniel Worrall(Harvard University), Kaitavjeet Chowdhary(Harvard University), Brenna McKaig, Liang Yang(Harvard University), Carl L. Lodenstein(Massachusetts General Hospital)
Cited by 179
Related Papers
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
The Human Cell Atlas
|Zurich Open Repository and Archive (University of Zurich)|2017|1.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
|Nature Communications|2017|1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981